Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums

Published On Sep 27, 2024, 4:00 PM

The Biden administration announced a decrease in monthly premiums for prescription drugs for older Americans in response to potential cost spikes that could have harmed the presidential campaign. By allocating funds from a Medicare trust fund, the administration aims to offset premium increases that were likely due to new cost caps and changes under the Inflation Reduction Act. This move is seen as politically motivated by critics, who argue that it provides only temporary relief and masks the larger issue of rising costs.

Read full article

Stock Forecasts

XLVView XLV chart on TradingView

Positive

Given the administration's proactive measures to maintain lower drug costs and appeal to older voters, companies in the health insurance and pharmaceutical sectors may see short-term stability or growth. However, criticisms of temporary fixes suggest potential long-term volatility for these sectors.

Related News

Life spans are growing but 'health spans' are shrinking. What that means for your money

Oct 9, 2024, 9:52 AM

Older Americans are spending more years with chronic ailments, which often come with higher medical bills, experts said.

XLV
VHT

Here's how AI is set to disrupt healthcare — albeit slowly

Oct 1, 2024, 2:22 PM

Healthcare and its big web of inefficiencies is thought to be a key arena for AI disruption. But investors might have to be very, very patient.

XLV

Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums

Sep 27, 2024, 4:00 PM

Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris.

XLV